RING finger E3 ligase PPP1R11 regulates TLR2 signaling and innate immunity - PubMed
- ️Fri Jan 01 2016
RING finger E3 ligase PPP1R11 regulates TLR2 signaling and innate immunity
Alison C McKelvey et al. Elife. 2016.
Abstract
Toll-like receptor 2 (TLR2) is a pattern recognition receptor that recognizes many types of PAMPs that originate from gram-positive bacteria. Here we describe a novel mechanism regulating TLR2 protein expression and subsequent cytokine release through the ubiquitination and degradation of the receptor in response to ligand stimulation. We show a new mechanism in which an uncharacterized RING finger E3 ligase, PPP1R11, directly ubiquitinates TLR2 both in vitro and in vivo, which leads to TLR2 degradation and disruption of the signaling cascade. Lentiviral gene transfer or knockdown of PPP1R11 in mouse lungs significantly affects lung inflammation and the clearance of Staphylococcus aureus. There is a negative correlation between PPP1R11 and TLR2 levels in white blood cell samples isolated from patients with Staphylococcus aureus infections. These results suggest that PPP1R11 plays an important role in regulating innate immunity and gram-positive bacterial clearance by functioning, in part, through the ubiquitination and degradation of TLR2.
Keywords: ARDS; E3 ligase; TLR2; biochemistry; human; immunology; innate immunity; mouse; ubiquitination; virus.
Conflict of interest statement
The authors declare that no competing interests exist.
Figures

(A) Murine lung epithelial (MLE) cells were treated with Pam3CSK4 with or without MG-132 or Leupeptin in a time-dependent manner. Cells were collected and immunoblotted for TLR2 and Actin. Endogenous TLR2 was also immunoprecipitated and followed by Ubiquitin immunoblotting. (B) MLE cells were pretreated with MG-132 for 18 hr to induce accumulation of polyubiquitinated TLR2 protein. Endogenous TLR2 was immunoprecipitated using TLR2 antibody and protein A/G beads. After washing, TLR2 beads were then incubated with different DUBs before being assayed for ubiquitin immunoblotting. (C) TLR2 protein half-life determination in MLE cells transfected with Empty plasmid or Ubiquitin plasmid. Cells were collected and immunoblotted for TLR2, HA, and Actin. Below the panel levels of each protein on immunoblots were quantified densitometrically (Normalized to time zero) and shown graphically. The data represent mean values ± SEM (n = 3); *, p<0.05, significant compared to Control, Student’s t-test. (D) Immunoblots showing levels of TLR2 proteins, V5, and Actin after PPP1R11 or PCGF1 plasmid dose over-expression. (E–F) TLR2 protein half-life determination in MLE cells with empty or PPP1R11 plasmid expression (E); TLR2 protein half-life determination with Control or PPP1R11 siRNA expression (F). Below each panel levels of each protein on immunoblots were quantified densitometrically (Normalized to time zero) and shown graphically. The data represent mean values ± SEM (n = 3); *p<0.05, significant compared to Control, Student’s t-test. (G) In vitro ubiquitination assay. Purified E1 and E2 components were incubated with TLR2-V5, PPP1R11, and the full complement of ubiquitination reaction components for different lengths of time. (H) In vitro ubiquitination assay. PPP1R11-V5 was incubated with purified E1, varying E2s, biotinylated ubiquitin, and the full complement of ubiquitination reaction components. The reaction mixture was subjected to streptavidin pulldown prior to V5 immunoblotting. (I) PPP1R11 protein was immunoprecipitated from cell lysate using a PPP1R11 antibody and coupled to protein A/G beads. PPP1R11 beads were then incubated with in vitrosynthesized products expressing V5‐tagged E2 conjugating enzymes. After washing, proteins were eluted and processed for V5 immunoblotting. (J) Endogenous PPP1R11 was also immunoprecipitated and immunoblotted for UBE2D. DOI:
http://dx.doi.org/10.7554/eLife.18496.002
(A) Coomassie blue staining of UBICrest supernatant following DuB assay. Stars represent indicated Dub signal (Figure 1B). (B) TLR2 immunoprecipitation from MLE cells prior to immunoblotting for K48-specific ubiquitin linkages. (C) TLR2 protein half-life study with MG132 or Leupeptin. Below the panel levels of each protein on immunoblots were quantified densitometrically and shown graphically. Data represent mean values ± SEM (n = 3); *p<0.05, significant compared to Control, Student’s t-test. (D) Immunoblots showing levels of TLR2 proteins and HA-Ubiquitin after ectopic Ubiquitin plasmid expression. DOI:
http://dx.doi.org/10.7554/eLife.18496.004
(A) MLE cells were transfected with LacZ or one of the other 10 randomly selected Ring-finger E3 ligases. 18 hr later, cells were collected and immunobloted. (B) TLR2 mRNA levels from MLE cells transfected with increasing amounts of PPP1R11. (C) TLR2 protein half-life determination with CON siRNA or PPP1R11 siRNA expression. Next to the panel levels of each protein on immunoblots were quantified densitometrically (Normalized to Time zero) and shown graphically. The data represent mean values ± SEM (n = 3); *p<0.05, significant compared to Control, Student’s t-test (D) Half-life determination with PCGF1 expression and (E) PCGF1 silencing in MLE cells. Next to the panel levels of each protein on immunoblots were quantified densitometrically (Normalized to Time zero) and shown graphically. The data represent mean values ± SEM (n = 3); NS, p>0.05, not significant compared to Control, Student’s t-test (F) Correlation between TLR2 and PPP1R11 levels in white blood cell samples from control patients (n = 8) compared to S. aureus-infected patients (n = 9). DOI:
http://dx.doi.org/10.7554/eLife.18496.006
(A) Schematic of putative atypical RING domains within PPP1R11. Candidate cysteine and histidine residues are listed, as well as a non-candidate H126. (B) MLE cells were transfected with increasing amounts of plasmid encoding WT or mutant PPP1R11. 18 hr later, cells were collected and immunoblotted for TLR2. DOI:
http://dx.doi.org/10.7554/eLife.18496.008
MLE cells were co-transfected with V5 tagged TLRs and increasing amounts of plasmid encoding PPP1R11. 18 hr later, cells were collected and immunoblotted for V5. DOI:
http://dx.doi.org/10.7554/eLife.18496.009
(A) MLE cells were treated with Pam3CSK4 in a time-dependent manner. Cells were collected and immunoblotted for PPP1R11, TLR2, and Actin. Endogenous TLR2 was also immunoprecipitated and immunoblotted for PPP1R11. (B) MLE cells were transfected with either empty or PPP1R11 plasmid. 24 hr later, cells were exposed to Pam3CSK4 in a time-dependent manner. Cells were collected and immunoblotted for V5, TLR2, and Actin. (C) MLE cells were transfected with either control or PPP1R11 siRNA. 48 hr later, cells were exposed to Pam3CSK4 in a time-dependent manner. Cells were collected and immunoblotted for V5, TLR2, and Actin. Endogenous TLR2 was also immunoprecipitated and followed by ubiquitin immunoblotting. (D–E) MLE cells were transfected with either empty, PPP1R11, or TRIM52 plasmid. 24 hr later, cells were exposed to Pam3CSK4 in a time-dependent manner. Cell media was then collected and assayed for IL-6 and CXCL1 (Data represent mean values ± SEM n = 4; *p<0.05, significant compared to Control, Student’s t-test). (F–G) MLE cells were transfected with either control or PPP1R11 siRNA. 48 hr later, cells were exposed to Pam3CSK4 in a time-dependent manner. Cell media was then collected and assayed for IL-6 and CXCL1 (Data represent mean values ± SEM n = 4; *p<0.05, significant compared to Control, Student’s t-test). DOI:
http://dx.doi.org/10.7554/eLife.18496.010
(A) Half-life study of WT and lysine mutant TLR2 in MLE cells. (B) MLE cells were transfected with WT or mutant TLR2 before Pam3CSK4 treatment. Cells were then immunoblotted for V5-TLR2. (C) In vitro ubiquitination assay using WT or K754R TLR2 as the substrate. (D) MLE cells were co-transfected with WT or TLR2 lysine mutants with or without PPP1R11. Cells were then collected and assayed for immunoblotting. (E) V5 tagged WT and K754R TLR2 were transfected in MLE cells. 18 hr later, cells were fixed, permeabilized, immunostained for V5 (Green). The nucleus was counterstained with DAPI, and F-actin was counterstained with Alexa 488-Phalloidin. (F–G) MLE cells were transfected with either control or Trim52 siRNA. 72 hr later, cells were exposed to Pam3CSK4 in a time-dependent manner. Cell media was then collected and assayed for IL-6 and CXCL1 (Data represent mean values ± SEM n = 3; NS, p>0.05, not significant compared to Control, Student’s t-test). DOI:
http://dx.doi.org/10.7554/eLife.18496.012
(A) Half-life study of TLR2 in Ppp1r11 CRISPR KO MLE cells and Ctrl MLE cells. The levels of each protein on immunoblots were quantified densitometrically (Normalized to Time zero) and shown graphically. The data represent mean values ± SEM (n = 3); *p<0.05, significant compared to Control, Student’s t-test. (B–C) Ppp1r11 KO and control cells were exposed to Pam3CSK4 in a time-dependent manner. Cell media was then collected and assayed for IL-6 and CXCL1 (Data represent mean values ± SEM n = 3; *p<0.05, significant compared to Control, Student’s t-test). DOI:
http://dx.doi.org/10.7554/eLife.18496.014
Lenti-Empty or Lenti-PPP1R11 (107PFU/mouse) was administered i.t. to C57BL/6J mice for 144 hr; mice were then infected i.t. with S. aureus (108 CFU). Mice were euthanized after 18 hr, and lungs were lavaged with saline, harvested, and then homogenized. Blood, liver, spleen, and kidney were also harvested and homogenized. (A–E) and (G). Lavage cytokines, BAL protein, BAL cell counts, and BAL bacterial counts were measured. The data represent mean values ± SEM (n = 8 mice per group; p<0.05, significant compared to Control, Student’s t-test). (F) and (H–K). Lung, blood, liver, spleen, and kidney bacterial counts were measured. The data represent mean values ± SEM (n = 8 mice per group; p<0.05, significant compared to Control, Student’s t-test). (L) H and E staining was performed on lung samples. Original magnification, 20X. Bar indicates 100 μm. (M) Mice lungs were isolated and assayed for TLR2, PPP1R11, and Actin immunoblotting. DOI:
http://dx.doi.org/10.7554/eLife.18496.016
Lenti-control shRNA or Lenti-PPP1R11 shRNA (107 PFU/mouse) was administered i.t. to C57BL/6J mice for 144 hr; mice were then infected i.t. with S. aureus (2.5*107 CFU). Mice were euthanized after 18 hr, and lungs were lavaged with saline, harvested, and then homogenized. Blood, liver, spleen, and kidney were also harvested and homogenized. (A–F) Lavage cytokines, BAL protein, BAL cell counts, and BAL bacterial counts were measured. The data represent mean values ± SEM (n = 8 mice per group; p<0.05, significant compared to Control, Student’s t-test). (G–I). Lung, blood, and liver bacterial counts were measured. The data represent mean values ± SEM (n = 8 mice per group; p<0.05, significant compared to Control, Student’s t-test).(J) H and E staining was performed on lung samples. Original magnification, 20X. Bar indicates 100 μm. (K) Mice lungs were isolated and assayed for TLR2, PPP1R11, and Actin immunoblotting. DOI:
http://dx.doi.org/10.7554/eLife.18496.018Similar articles
-
Skerrett SJ, Braff MH, Liggitt HD, Rubens CE. Skerrett SJ, et al. Physiol Rep. 2017 Nov;5(21):e13491. doi: 10.14814/phy2.13491. Physiol Rep. 2017. PMID: 29142002 Free PMC article.
-
Yimin, Kohanawa M, Zhao S, Ozaki M, Haga S, Nan G, Kuge Y, Tamaki N. Yimin, et al. PLoS One. 2013 Sep 13;8(9):e74287. doi: 10.1371/journal.pone.0074287. eCollection 2013. PLoS One. 2013. PMID: 24058538 Free PMC article.
-
Smeland TE, Müller F, Blomfeldt A, Stavem K, Aamot HV. Smeland TE, et al. APMIS. 2017 Oct;125(10):927-932. doi: 10.1111/apm.12734. Epub 2017 Jul 24. APMIS. 2017. PMID: 28736863
-
Recognition of Staphylococcus aureus by the innate immune system.
Fournier B, Philpott DJ. Fournier B, et al. Clin Microbiol Rev. 2005 Jul;18(3):521-40. doi: 10.1128/CMR.18.3.521-540.2005. Clin Microbiol Rev. 2005. PMID: 16020688 Free PMC article. Review.
-
Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus.
Pietrocola G, Arciola CR, Rindi S, Di Poto A, Missineo A, Montanaro L, Speziale P. Pietrocola G, et al. Int J Artif Organs. 2011 Sep;34(9):799-810. doi: 10.5301/ijao.5000030. Int J Artif Organs. 2011. PMID: 22094559 Review.
Cited by
-
Starling AP, Liu C, Shen G, Yang IV, Kechris K, Borengasser SJ, Boyle KE, Zhang W, Smith HA, Calafat AM, Hamman RF, Adgate JL, Dabelea D. Starling AP, et al. Environ Health Perspect. 2020 Dec;128(12):127014. doi: 10.1289/EHP6888. Epub 2020 Dec 24. Environ Health Perspect. 2020. PMID: 33356526 Free PMC article.
-
Tankyrase represses autoinflammation through the attenuation of TLR2 signaling.
Matsumoto Y, Dimitriou ID, La Rose J, Lim M, Camilleri S, Law N, Adissu HA, Tong J, Moran MF, Chruscinski A, He F, Asano Y, Katsuyama T, Sada KE, Wada J, Rottapel R. Matsumoto Y, et al. J Clin Invest. 2022 Apr 1;132(7):e140869. doi: 10.1172/JCI140869. J Clin Invest. 2022. PMID: 35362478 Free PMC article.
-
RING finger protein 113A regulates C-X-C chemokine receptor type 4 stability and signaling.
Lear T, Dunn SR, McKelvey AC, Mir A, Evankovich J, Chen BB, Liu Y. Lear T, et al. Am J Physiol Cell Physiol. 2017 Nov 1;313(5):C584-C592. doi: 10.1152/ajpcell.00193.2017. Epub 2017 Oct 4. Am J Physiol Cell Physiol. 2017. PMID: 28978524 Free PMC article.
-
KIAA0317 regulates pulmonary inflammation through SOCS2 degradation.
Lear TB, McKelvey AC, Evankovich JW, Rajbhandari S, Coon TA, Dunn SR, Londino JD, McVerry BJ, Zhang Y, Valenzi E, Burton CL, Gordon R, Gingras S, Lockwood KC, Jurczak MJ, Lafyatis R, Shlomchik MJ, Liu Y, Chen BB. Lear TB, et al. JCI Insight. 2019 Oct 3;4(19):e129110. doi: 10.1172/jci.insight.129110. JCI Insight. 2019. PMID: 31578312 Free PMC article.
-
Liu G, Wu J, Qiao M, Zhou J, Wu H, Peng X, Mekchay S, Mei S. Liu G, et al. Cell Cycle. 2019 May;18(9):1033-1044. doi: 10.1080/15384101.2019.1610241. Epub 2019 May 1. Cell Cycle. 2019. PMID: 31014175 Free PMC article.
References
-
- Bronkhorst MW, Boyé ND, Lomax MA, Vossen RH, Bakker J, Patka P, Van Lieshout EM. Single-nucleotide polymorphisms in the Toll-like receptor pathway increase susceptibility to infections in severely injured trauma patients. Journal of Trauma and Acute Care Surgery. 2013;74:862–870. doi: 10.1097/TA.0b013e31827e1534. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous